Clinical Trial Update: Neoadjuvant Radiotherapy Plus Targeted Therapy and Immunotherapy vs. Targeted Therapy Plus Immunotherapy in Resectable HNSCC [Phase 2]

View source ↗

Summary

Phase 2 trial investigating neoadjuvant radiotherapy combined with targeted therapy and immunotherapy versus targeted therapy and immunotherapy for resectable h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: West China Hospital | Conditions: Head and Neck Cancer | Phase 2 | Status: WITHDRAWN